Law ❯ Litigation ❯ Securities Litigation ❯ Class Action Lawsuits

Telix Pharmaceuticals

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

Investors have until January 9, 2026 to seek lead-plaintiff status under the PSLRA.